Munich, DE – Biotech startup IRUBIS, developing a state-of- the - art real - time bioprocess monitoring solution, has successfully closed a pre- series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as [...]

BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets [...]

Sensific GmbH, a German leader in advanced optical measurement and automation systems, is pleased to announce a strategic partnership with 微纳立方科技（北京）有限公司 (Microblox), a premier provider of comprehensive microfluidics laboratory solutions in China. This collaboration will see Microblox become the official distributor of Sensific’s innovative microfluidics-based products across the Chinese market. Sensific GmbH is renowned for its pioneering [...]

Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more LELAND, N.C. & SAN DIEGO -- Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have [...]

CALIBRE SCIENTIFIC ACQUIRES CONEX CHROMATOGRAPHY SYSTEMS, A UK PROVIDER OF CHROMATOGRAPHY INSTRUMENTS, CONSUMABLES AND SERVICES LOS ANGELES, CA — Calibre Scientific is pleased to announce the acquisition of Conex Chromatography Systems Limited (“Conex” or the “Company”), a provider of chromatography instruments, consumables, and services catering to life sciences, pharmaceutical, academic, petrochemical, nuclear energy, and the [...]

Thomas Unt, the CEO of SmiLe Inject Capital Lund, Sweden – SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe and [...]

TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic claims The 500+ gene biomarker test advances access to localized precision oncology for patients SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval [...]

Natick, MA – Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the global launch of oncoReveal™ Nexus, a research-use-only (RUO) next-generation sequencing (NGS) kit designed to enable laboratories with a rapid, targeted solution for solid and hematological malignancies to help accelerate the delivery of targeted therapy. A team at New York’s Memorial Sloan Kettering Cancer [...]

QUANTUM-SI ANNOUNCES NEW EXECUTIVE TEAM MEMBERS TO ACCELERATE THE EVOLUTION OF THE COMPANY INTO A LEADING PROTEOMIC TOOL PROVIDER Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Todd Bennett will join QSI as the Company’s new Chief Commercial Officer effective September 17, 2024, John Vieceli, Ph.D. has been named Chief Product Officer [...]

Global provider of digital engineering and development services to drive implementation of the Sapio Platform Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced that EPAM, a leading global provider of digital platform engineering and development services, has joined the Sapio Sciences Partner Program as a services partner, delivering consulting and implementation services to the complex health [...]